company background image
0A05 logo

Medacta Group LSE:0A05 Stock Report

Last Price

CHF 137.60

Market Cap

CHF 2.7b

7D

-0.4%

1Y

6.7%

Updated

23 Feb, 2025

Data

Company Financials +

0A05 Stock Overview

Develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. More details

0A05 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Medacta Group SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medacta Group
Historical stock prices
Current Share PriceCHF 137.60
52 Week HighCHF 140.60
52 Week LowCHF 105.80
Beta1.22
1 Month Change23.54%
3 Month Change21.13%
1 Year Change6.66%
3 Year Change22.62%
5 Year Change62.46%
Change since IPO44.36%

Recent News & Updates

Recent updates

Shareholder Returns

0A05GB Medical EquipmentGB Market
7D-0.4%0.8%-0.9%
1Y6.7%-7.0%9.8%

Return vs Industry: 0A05 exceeded the UK Medical Equipment industry which returned -7% over the past year.

Return vs Market: 0A05 underperformed the UK Market which returned 9.8% over the past year.

Price Volatility

Is 0A05's price volatile compared to industry and market?
0A05 volatility
0A05 Average Weekly Movement4.8%
Medical Equipment Industry Average Movement6.8%
Market Average Movement4.6%
10% most volatile stocks in GB Market10.6%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0A05 has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0A05's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19581,826Francesco Siccardiwww.medacta.com

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Medacta Group SA Fundamentals Summary

How do Medacta Group's earnings and revenue compare to its market cap?
0A05 fundamental statistics
Market capCHF 2.74b
Earnings (TTM)CHF 52.76m
Revenue (TTM)CHF 510.83m

51.9x

P/E Ratio

5.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0A05 income statement (TTM)
Revenue€544.29m
Cost of Revenue€174.57m
Gross Profit€369.72m
Other Expenses€313.51m
Earnings€56.21m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Mar 25, 2025

Earnings per share (EPS)2.82
Gross Margin67.93%
Net Profit Margin10.33%
Debt/Equity Ratio54.1%

How did 0A05 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

21%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/23 02:30
End of Day Share Price 2025/02/21 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medacta Group SA is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Maria Vara FernándezBryan Garnier & Co
Christoph GretlerCredit Suisse